2018 BMT Tandem Meetings

Xenikos will be attending the 2018 BMT Tandem Meetings. If you would like to arrange a one-on-one meeting with Xenikos' management team during the conference, please contact Ypke van Oosterhout, CEO, at This email address is being protected from spambots. You need JavaScript enabled to view it. or Eric van Hooren, CDO, at This email address is being protected from spambots. You need JavaScript enabled to view it..

The BMT Tandem Meetings are the combined annual meetings of CIBMTR (Center for International Blood & Marrow Transplant Research) and the American Society of Blood and Marrow Transplantation (ASBMT), offering a full scientific program that addresses the most timely issues in hematopoietic cell transplantation.

The data from T-Guard Phase I/II trial will be presented at the 2017 ASH Annual Meeting and Exposition

December 9-12, 2017 - Atlanta Georgia World Congress Center

Xenikos will be attending the 59th ASH Annual Meeting and Exposition. The data from T-Guard Phase I/II trial will be presented at this event. If you would like to arrange a one-on-one meeting with Xenikos' management team during the conference, please contact Ypke van Oosterhout, CEO, at This email address is being protected from spambots. You need JavaScript enabled to view it. or Annick Stijns, Public Affairs & Project Management at This email address is being protected from spambots. You need JavaScript enabled to view it..

2018 J.P. Morgan 36th Annual Healthcare Conference

January 8-11, 2018 – San Francisco, CA, USA

Xenikos will be attending the J.P. 36th Annual Healthcare Conference. If you would like to arrange a one-on-one meeting with Xenikos' management team during the conference, please contact Ypke van Oosterhout, CEO, at This email address is being protected from spambots. You need JavaScript enabled to view it. or Annick Stijns, Public Affairs & Project Management at This email address is being protected from spambots. You need JavaScript enabled to view it..

European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) Working Breakfast

November 28, 2017 - BrusselsMembers’ Restaurant, European Parliament

Xenikos has been invited to participate in a panel discussion, “How to foster Europe as an R&D hub of pharmaceutical SMEs?” sponsored by EUCOPE on November 28, 2017 at the European Parliament in Brussels, Belgium. Ypke van Oosterhout, CEO of Xenikos will represent the Company at this event.

With the long-awaited European Commission’s study of the impact of pharmaceutical incentives and patent SPCs (supplementary protection certificates) on innovation, availability and accessibility of medicinal products in the European Union (EU) expected by early 2018, the panel will discuss the conditions that foster pharmaceutical and biotech innovation in the EU and highlight the possible impacts on SMEs (small and medium-sized enterprises) that a change to incentive policies in the pharmaceutical sector could bring.

Other speakers will include members of the EU Commission, EU Parliament and industry trade association representatives. Attendees are expected to include EU Commission members, venture capitalists and pharmaceutical companies.

If you would like to arrange a one-on-one meeting with Xenikos' management team during the conference, please contact Ypke van Oosterhout, CEO, at This email address is being protected from spambots. You need JavaScript enabled to view it. or Annick Stijns, Public Affairs & Project Management at This email address is being protected from spambots. You need JavaScript enabled to view it..